Century Therapeutics, Inc.
IPSCHealthcare|Biotechnology|US
$1.68
+0.17 (+11.26%)
DCF Value
$2.59
Tangible Book / Share
$0.96
Cash / Share
$0.58
Clinical Trials (16)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07243704 Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage | Intracerebral Haemorrhage | P3 | Recruiting | 5,676 | RCT, Double-blind | Aspirin 75 mg daily, Placebo |
| NCT06255028 A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases | Systemic Lupus Erythematosus, Lupus Nephritis | P1 | Active | 6 | Open-label | CNTY-101, IL-2, Lymphodepleting Chemotherapy |
| NCT05768269 A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product | Hematological Malignancy, Solid Tumor Malignancy | Recruiting | 375 | — | — | |
| NCT01400815 Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid | Smoking Cessation | P2 | Completed | 234 | RCT, Double-blind | X-22 Smoking Cessation Product, Active Control Cigarettes |
| NCT04050111 The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis | Knee Osteoarthritis | P2 | Unknown | 30 | Open-label | Stromal-vascular fraction |
| NCT05336409 A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies | R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma | P1 | Terminated | 28 | Open-label | CNTY-101, IL-2, Lymphodepleting Chemotherapy |
| NCT03559751 Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes | Tobacco Use | P1 | Completed | 66 | RCT, Open-label | Nicotine gum (C) |
| NCT03559725 Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes | Tobacco Use | P1 | Completed | 55 | RCT, Open-label | Nicotine gum (C) |
| NCT07068061 PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture) | Wrinkles, Anti Aging | N/A | Not Yet Recruiting | 50 | Open-label | — |
| NCT04420728 Closed-Loop Insulin in Mothers With Type 1 Diabetes and Baby Feeding Practices | Diabetes Mellitus Type 1 Pre-Existing, Pregnancy Related | N/A | Completed | 20 | RCT, Open-label | — |
| NCT03692936 Computed Tomography Derived Fractional Flow Reserve for Coronary Hemodynamic Ischemia Noninvasive Assessment | Coronary Artery Disease | Unknown | 326 | — | — | |
| NCT02903862 Health-eBrain Study | Depression and Burden in Caregivers | N/A | Withdrawn | — | Open-label | — |
| NCT01402609 Assessing the Efficacy of an Electronic Discharge Communication Tool | Other Diagnoses, Comorbidities, and Complications | N/A | Completed | 1,399 | RCT, Single-blind | — |
| NCT02325388 Pressure Sensing to Reduce the Risk of Pressure Ulcer Formation | Pressure Ulcer | N/A | Completed | 678 | RCT, Single-blind | — |
| NCT03571724 A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes | Tobacco Use | N/A | Completed | 142 | RCT, Open-label | — |
| NCT04775836 An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases | Stroke, Cerebrovascular Diseases | Unknown | 300,000 | — | — |